Key Financial Data Of Group

OncoTherapy Science, Inc. - Filing #7719217

Concept 2018-07-01 to
2018-09-30
2018-04-01 to
2018-09-30
As at
2018-09-30
2017-04-01 to
2018-03-31
As at
2018-03-31
2017-07-01 to
2017-09-30
2017-04-01 to
2017-09-30
As at
2017-09-30
Key financial data of group
Business results of group
Ordinary profit (loss)
-1,734,666,000 JPY
-2,977,177,000 JPY
-1,422,985,000 JPY
Profit (loss) attributable to owners of parent
-1,542,231,000 JPY
-2,851,092,000 JPY
-1,367,154,000 JPY
Comprehensive income
-1,718,056,000 JPY
-2,927,183,000 JPY
-1,371,235,000 JPY
Net assets
5,843,025,000 JPY
7,579,839,000 JPY
8,830,066,000 JPY
Total assets
6,251,233,000 JPY
8,021,524,000 JPY
9,206,417,000 JPY
Basic earnings (loss) per share
-6.09
-10.49
-19.39
-5.43
-9.30
Diluted earnings per share
Equity-to-asset ratio
0.869 xbrli:pure
0.870 xbrli:pure
0.905 xbrli:pure
Net cash provided by (used in) operating activities
-1,333,631,000 JPY
-3,035,947,000 JPY
-1,498,268,000 JPY
Net cash provided by (used in) investing activities
-67,153,000 JPY
-446,421,000 JPY
-37,941,000 JPY
Net cash provided by (used in) financing activities
JPY
150,640,000 JPY
150,640,000 JPY
Cash and cash equivalents
5,339,245,000 JPY
6,740,238,000 JPY
8,686,276,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.